Detalhe da pesquisa
1.
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Respir Res
; 24(1): 106, 2023 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031164
2.
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients.
Europace
; 25(9)2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552791
3.
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis
; 20: 14799731231202257, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800633
4.
Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.
J Asthma
; 59(6): 1213-1220, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764239
5.
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Respir Res
; 22(1): 279, 2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711232
6.
Measuring disease activity in COPD: is clinically important deterioration the answer?
Respir Res
; 21(1): 134, 2020 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487202
7.
Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease (PREM-C9).
Thorax
; 74(6): 600-603, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028236
8.
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.
J Cardiovasc Electrophysiol
; 30(7): 1066-1077, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938894
9.
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
Respir Res
; 20(1): 238, 2019 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666084
10.
Long-term outcomes following first short-term clinically important deterioration in COPD.
Respir Res
; 19(1): 222, 2018 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30453972
11.
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
Pulm Pharmacol Ther
; 49: 11-19, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29277690
12.
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Europace
; 20(FI2): f240-f248, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29771327
13.
Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown.
J Card Fail
; 28(8): 1372-1374, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690314
14.
Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
Respir Res
; 18(1): 86, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482883
15.
Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study.
Europace
; 19(11): 1841-1847, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27702867
16.
Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.
Respirology
; 22(5): 928-934, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28001000
17.
White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.
BMC Pulm Med
; 17(1): 92, 2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629404
18.
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.
Thorax
; 71(7): 587-93, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917577
19.
Blood eosinophils and inhaled corticosteroid/long-acting ß-2 agonist efficacy in COPD.
Thorax
; 71(2): 118-25, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26585525
20.
Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
J Cardiovasc Electrophysiol
; 27(10): 1183-1190, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334356